Hackensack Meridian Health

Neptune City, New Jersey 07753

1 studies enrolling now · 5 studies all time

What they study most

Berger Disease, Bergers Disease, EGFRI Induced Acneiform Lesions, Epilepsy, IgA Nephropathy, Immunoglobulin A Nephropathy, Nephritis IgA Type, Nephropathy IgA Type, Non-Small Cell Lung Cancer, Oral Mucositis, Primary IgAN, Squamous Cell Carcinoma of the Oral Cavity and Oropharynx

Studies at this site

• Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN — Recruiting now
• Evaluation of the 24/7 EEG SubQ System for Ultra Long-Term Recording of Patients With Epilepsy Involving the Temporal Lobe Region. — Stopped early
• Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients) — Running, not enrolling
• LUT014 for the Reduction of Dose-Limiting Acneiform Lesions Associated With EGFRI Treatment of mCRC — Status unconfirmed
• DOM-INNATE: Study of SGX942 for the Treatment of Oral Mucositis in Patients With Concomitant Chemoradiation Therapy for Head and Neck Cancer — Completed